Drugs by condition
Drugs approved for c. difficile infection
Last checked: Nov 19, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations
Brand-name drugs approved
7
Still marketed, NDA or BLA
Drug classes
2
Novel drugs
3
New molecular entities and new biologics
In development
4
Investigational drugs in Phase 2 or 3
Newest approvals
The most recently first-approved brand-name drugs for c. difficile infection.
- Vancomycin Hydrochloride (Vancomycin Hydrochloride) · Zhejiang Novus Pharm Jan 20, 2023
- Dificid (Fidaxomicin) · Cubist Pharms LLC Priority reviewOrphanJan 24, 2020
- Firvanq Kit (Vancomycin Hydrochloride) · Azurity Priority reviewJan 26, 2018
- Zinplava (Bezlotoxumab) · Merck Sharp Dohme NovelPriority reviewOct 21, 2016
- Dificid (Fidaxomicin) · Cubist Pharms LLC NovelPriority reviewOrphanMay 27, 2011
All approved drugs for c. difficile infection, by class
Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 20 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.
Macrolide Antibacterial (2)
Class not listed in FDA's data (5)
- Zinplava Bezlotoxumab · Merck Sharp Dohme · 2016
- Cefotan Cefotetan Disodium · Pai Holdings Pharm · 1985
- Vancomycin Hydrochloride Vancomycin Hydrochloride · Zhejiang Novus Pharm · 2023
- Firvanq Kit Vancomycin Hydrochloride · Azurity · 2018
- Vancocin Hydrochloride Vancomycin Hydrochloride · Ani Pharms · 1986
Drugs in development for c. difficile infection
Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.
- LMN-201Phase 31 trial
Lumen Bioscience, Inc. · Clostridioides Difficile Infection
- VE303Phase 31 trial
Vedanta Biosciences, Inc. · Clostridium Difficile, Clostridium Difficile Infections, Clostridium Difficile Infection Recurrence
- AZD5148Phase 21 trial
AstraZeneca · Clostridioides Difficile Infection
- IbezapolstatACX-362EPhase 21 trial
Acurx Pharmaceuticals Inc. · Clostridium Difficile Infection Recurrence
More on c. difficile infection: recruiting trials · published research
Related in infectious disease and vaccines: HIV · Hepatitis B · Hepatitis C · COVID-19 · Influenza · RSV · Urinary tract infection · Pneumonia · Skin infections · Fungal infections
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.